See The President's Message on 2005 & 2006

Vision: The purpose and development of CardioVascular BioTherapeutics, Inc. is to assist in extending life through the use of FGF-1141, our drug candidate that addresses cardiovascular disease by increasing the blood supply to ischemic areas, organs and tissues of the body. Once blood perfusion is established through the growth of new blood vessels in areas affected, patients with cardiovascular disease can experience an increase in life expectancy and quality of life.

Mission: Our mission at CardioVascular BioTherapeutics, Inc. is to provide treatment for different types of cardiovascular disease.  CVBT is determined to achieve this primary goal and accomplish this humanitarian objective, which could potentially help millions of people who suffer from such diseases.

Our Goals: CVBT must accomplish three key goals in order to succeed in its mission:

1. Become a commercially viable business.
2. Conduct our actions in a manner that allows everyone to trust in our integrity to do the right thing.
3. Continue to identify and develop revolutionary new medical treatments for the number one cause of death in the developed world.

Use of this site constitutes agreement to our Terms and Conditions
and Privacy Policy. Site Design and Contents © 2008 CardioVascular BioTherapeutics, Inc. All Rights Reserved.

Some content on this site requires the free Adobe Reader.